Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents. The new compound, called ProCA32.collagen1 ...

May 15, 2006 -- Combined contrast-enhanced magnetic resonance imaging (CCE MRI) is an accurate, noninvasive method for staging liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), ...

Recent advances in CT, MRI, ultrasound, and AI are transforming liver disease diagnosis, enabling earlier, more accurate, and less invasive detection of conditions like fibrosis, steatosis, and ...

Researchers from France have shown that hepatobiliary MR contrast agent uptake can predict survival in patients with resectable hepatocellular carcinoma (HCC) as well as 18 F-FDG PET/CT can. They ...

A new compound has been invented to bind to liver cells that are in the early stages of damage, thus making it easier to pick them up using MRI (magnetic resonance imaging). As reported in the journal ...

Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...

CHICAGO--(BUSINESS WIRE)--Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the ...

BOSTON - Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image quality and allows radiologists who interpret MRI scans to pick up subtle anatomic details ...